UBS AM’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.2M | Sell |
|
|||||
|
2025
Q1 | $104M | Buy |
|
|||||
|
2024
Q4 | $32.9M | Sell |
|
|||||
|
2024
Q3 | $40.9M | Sell |
|
|||||
|
2024
Q2 | $46.2M | Buy |
|
|||||
|
2024
Q1 | $3.25M | Sell |
|
|||||
|
2023
Q4 | $2.53M | Hold |
|
|||||
|
2023
Q3 | $2.37M | Buy |
|
|||||
|
2023
Q2 | $1.34M | Hold |
|
|||||
|
2023
Q1 | $1.34M | Buy |
|
|||||
|
2022
Q4 | $1.23M | Sell |
|
|||||
|
2022
Q3 | $1.13M | Buy |
|
|||||
|
2022
Q2 | $998K | Hold |
|
|||||
|
2022
Q1 | $1.01M | Buy |
|
|||||
|
2021
Q4 | $713K | Buy |
|
|||||
|
2021
Q3 | $454K | Hold |
|
|||||
|
2021
Q2 | $592K | Sell |
|
|||||
|
2021
Q1 | $722K | Sell |
|
|||||
|
2020
Q4 | $640K | Hold |
|
|||||
|
2020
Q3 | $459K | Buy |
|
|||||
|
2020
Q2 | $224K | Sell |
|
|||||
|
2020
Q1 | $254K | Buy |
|
|||||
|
2019
Q4 | $227K | Buy |
|